|
0
|
|
How to safely discontinue antifungal treatment in invasive pulmonary aspergillosis?-clinical considerations in haematology.
(linkinghub.elsevier.com)
|
Stemler J
…
Cornely OA
Clinical Microbiology and Infection
2026-06-01
|
#infection
#antifungal
#biomarker
#aspergillosis
#immunocompromised
|
|
0
|
|
Therapeutic Challenges in Case of Trichophyton indotineae Dermatophytosis, Singapore, 2025.
(wwwnc.cdc.gov)
|
Foo TJ
…
Wu SJ
Emerging Infectious Diseases
2026-06-01
|
#infection
#amr
#antifungal
|
|
0
|
|
Wickerhamomyces anomalus Fungemia during Healthcare-Associated Outbreak, Pereira, Colombia, 2025.
(wwwnc.cdc.gov)
|
Ordonez KM
…
Meis JF
Emerging Infectious Diseases
2026-06-01
|
#infection
#antifungal
#genotyping
#nosocomial
#fungemia
|
|
0
|
|
MoCox6 is a regulator of mitophagy and a druggable target in Magnaporthe oryzae.
(nature.com)
|
Wu MH
…
Liu XH
Nature Microbiology
2026-06-01
|
#virulence
#antifungal
#autophagy
#drug discovery
#mitophagy
|
|
0
|
|
Structural basis of fungal beta-1,3-glucan synthase inhibition by caspofungin.
(nature.com)
|
Ren Z
…
Lee SY
Nature
2026-06-01
|
#amr
#cryo-em
#catalysis
#antifungal
|
|
0
|
|
In Vitro Antifungal Drug Susceptibility of Feline Sporothrix schenckii Complex Isolates, Thailand, 2023-2025.
(wwwnc.cdc.gov)
|
Yurayart C
…
Sattasathuchana P
Emerging Infectious Diseases
2026-06-01
|
#susceptibility
#surveillance
#antifungal
#zoonosis
#sporotrichosis
|